ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

ADPT Adaptive Biotechnologies Corporation

3,01
0,08 (2,73%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Adaptive Biotechnologies Corporation ADPT NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,08 2,73% 3,01 01:01:20
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
2,99 2,95 3,14 3,01 2,93
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
17.4.202422:05GLOBEAdaptive Biotechnologies to Report First Quarter 2024..
02.4.202422:05GLOBEAdaptive Biotechnologies Provides Strategic Review Update..
27.3.202413:30GLOBEAdaptive Biotechnologies to Hold a Business Update..
07.3.202401:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202401:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202401:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202401:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202401:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202401:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202401:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202401:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202401:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202401:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202401:38EDGAR2Form 3 - Initial statement of beneficial ownership of..
22.2.202422:05GLOBEAdaptive Biotechnologies to Present at the TD Cowen 44th..
14.2.202422:15EDGAR2Form 8-K - Current report
14.2.202422:05GLOBEAdaptive Biotechnologies Reports Fourth Quarter and Full..
29.1.202422:05GLOBEAdaptive Biotechnologies to Report Fourth Quarter and Full..
29.1.202422:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
27.12.202322:05GLOBEAdaptive Biotechnologies to Present at the 42nd Annual J.P...
09.12.202314:30GLOBEAdaptive Biotechnologies Announces New Data Highlighting the..
05.12.202313:30GLOBEAdaptive Biotechnologies and Collaborators to Present More..
20.11.202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.11.202322:15EDGAR2Form 8-K - Current report
09.11.202322:05GLOBEAdaptive Biotechnologies Reports Third Quarter 2023..
07.11.202313:30GLOBEAdaptive Biotechnologies Announces New Translational..
02.11.202321:05GLOBEAdaptive Biotechnologies to Report Third Quarter Financial..
13.9.202313:30GLOBEAdaptive Announces Launch of Epic Integration for clonoSEQ®
01.9.202323:16EDGAR2Form 8-K - Current report
30.8.202322:30GLOBEAdaptive Biotechnologies to Participate in the Morgan..
08.8.202323:26EDGAR2Form 144 - Report of proposed sale of securities
08.8.202322:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.8.202322:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.8.202322:17EDGAR2Form 8-K - Current report
02.8.202322:05GLOBEAdaptive Biotechnologies Reports Second Quarter 2023..
10.7.202322:05GLOBEAdaptive Biotechnologies to Report Second Quarter Financial..
03.7.202321:14EDGAR2Form 8-K - Current report
02.6.202313:34GLOBEAdaptive Biotechnologies Highlights New Data at ASCO 2023..
24.5.202322:05GLOBEAdaptive Biotechnologies to Participate in Upcoming June..
12.5.202314:00GLOBEAdaptive Biotechnologies to Participate in the 2023 RBC..
09.5.202313:30GLOBEAdaptive Biotechnologies Announces FDA Acceptance of..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock